| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.15B | 11.83B | 10.07B | 8.41B | 6.62B | 5.11B |
| Gross Profit | 5.28B | 4.68B | 3.62B | 2.95B | 2.32B | 1.88B |
| EBITDA | 3.09B | 2.59B | 1.97B | 1.60B | 1.25B | 1.11B |
| Net Income | 738.68M | 520.96M | 731.00M | 565.00M | 512.00M | 310.00M |
Balance Sheet | ||||||
| Total Assets | 16.98B | 16.14B | 12.86B | 10.78B | 7.95B | 5.71B |
| Cash, Cash Equivalents and Short-Term Investments | 3.02B | 3.14B | 1.99B | 1.29B | 935.08M | 794.46M |
| Total Debt | 5.56B | 5.78B | 4.53B | 4.46B | 2.31B | 1.38B |
| Total Liabilities | 12.37B | 11.88B | 9.57B | 8.84B | 6.00B | 4.21B |
| Stockholders Equity | 3.89B | 3.57B | 2.79B | 1.86B | 1.73B | 1.05B |
Cash Flow | ||||||
| Free Cash Flow | 2.64B | 2.57B | 1.89B | 1.63B | 1.15B | 1.22B |
| Operating Cash Flow | 2.71B | 2.64B | 1.95B | 1.68B | 1.19B | 1.24B |
| Investing Cash Flow | -2.39B | -1.97B | -1.52B | -1.67B | -1.65B | -1.22B |
| Financing Cash Flow | 153.29M | 358.16M | 277.98M | 456.28M | 540.42M | -983.21K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | C$4.57B | 38.60 | 19.72% | ― | 16.06% | 744.14% | |
75 Outperform | C$8.84B | 35.40 | 10.76% | ― | 11.62% | 19.63% | |
74 Outperform | C$872.52M | 12.06 | 11.48% | 5.69% | -4.08% | -7.65% | |
69 Neutral | C$7.41B | 10.72 | 12.93% | 3.27% | -0.86% | -16.61% | |
67 Neutral | C$64.81B | 59.94 | 20.79% | 0.17% | 16.36% | -0.70% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | C$1.86B | -9.28 | -9.59% | ― | 13.25% | 77.06% |